SCOPUS 정보 검색 플랫폼

Volumn 6, Issue 9, 2000, Pages 3442-3450

Phase II trial of interleukin 2, interferon α and 5-fluorouracil in metastatic renal cell cancer: A Cytokine Working Group Study

(11) Dutcher, J P a Logan, T a Gordon, M a Sosman, J a Weiss, G a Margolin, K a Plasse, T a Mier, J a Lotze, M a Clark, J a Atkins, M a

a OUR LADY OF MERCY MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; KIDNEY CARCINOMA; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INTERFERON ALFA-2B; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; OUTPATIENTS; QUALITY OF LIFE; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 0033812694 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (86)

References (56)

1
- 0028266553
- The treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2
- (1994) J. Am. Med. Assoc. , vol.271 , pp. 907-913
- Rosenberg, S.A.¹ Yang, J.C.² Topalian, S.L.³ Schwartentruber, D.J.⁴ Weber, J.S.⁵ Parkinson, D.R.⁶ Seipp, C.A.⁷ Einhorn, J.H.⁸ White, D.E.⁹

2
- 0023920994
- Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells - A Phase II clinical trial
- (1988) Ann. Intern. Med. , vol.108 , pp. 518-523
- Fisher, R.I.¹ Coltman C.A., Jr.² Doroshow, J.H.³ Rayner, A.A.⁴ Hawkins, M.J.⁵ Mier, J.W.⁶ Wiernik, P.H.⁷ McMannis, J.D.⁸ Weiss, G.R.⁹ Margolin, K.A.¹⁰ Gemlo, B.T.¹¹ Hoth, D.F.¹² Parkinson, D.R.¹³ Paietta, E.¹⁴

3
- 0027462554
- Randomized Phase II trial of high dose interleukin-2 either alone or in combination with interferon α-2b in advanced renal cell carcinoma
- (1993) J. Clin. Oncol. , vol.11 , pp. 661-670
- Atkins, M.B.¹ Sparano, J.² Fisher, R.I.³ Weiss, G.R.⁴ Margolin, K.A.⁵ Fink, K.I.⁶ Rubinstein, L.⁷ Louie, A.⁸ Mier, J.W.⁹ Gucalp, R.¹⁰ Sosman, J.A.¹¹ Boldt, D.H.¹² Doroshow, J.H.¹³ Aronson, F.R.¹⁴ Sznol, M.¹⁵

4
- 0028929682
- Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy
- (1995) J. Clin. Oncol. , vol.13 , pp. 688-696
- Fyfe, G.¹ Fisher, R.I.² Rosenberg, S.A.³ Sznol, M.⁴ Parkinson, D.R.⁵ Louie, A.C.⁶

5
- 0023123517
- Constant infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer
- (1987) N. Engl. J. Med. , vol.316 , pp. 898-905
- West, W.H.¹ Tauer, K.W.² Yanelli, J.R.³ Marshall, G.D.⁴ Orr, D.W.⁵ Thurman, G.B.⁶ Oldham, R.K.⁷

6
- 0025062390
- A Phase II trial of high dose intermittent interleukin-2 in metastatic renal cell carcinoma. A Southwest Oncology Group Study
- (1990) J. Natl. Cancer Inst. , vol.82 , pp. 1202-1206
- Bukowski, R.M.¹ Goodman, P.² Crawford, E.D.³ Sergi, J.S.⁴ Redan, B.G.⁵ Whitehead, R.P.⁶

7
- 0024514149
- Toxicity of interleukin-2 and lymphokine-activated killer (LAK) cell therapy
- (1989) J. Clin. Oncol. , vol.7 , pp. 486-489
- Margolin, K.¹ Rayner, A.A.² Hawkins, M.³ Atkins, M.⁴ Dutcher, J.P.⁵ Fisher, R.I.⁶ Weiss, G.R.⁷ Doroshow, J.H.⁸ Jaffe, H.S.⁹ Roper, M.¹⁰ Parkinson, D.R.¹¹ Wiernik, P.H.¹² Creekmore, S.P.¹³ Boldt, D.H.¹⁴

8
- 0028106484
- Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: An interim report
- (1994) J. Clin. Oncol. , vol.12 , pp. 1572-1576
- Yang, J.C.¹ Topalian, S.L.² Parkinson, D.³ Schwartzentruber, D.J.⁴ Weber, J.S.⁵ Ettinghausen, S.E.⁶ White, D.E.⁷ Steinberg, S.M.⁸ Cole, D.J.⁹ Kim, H.I.¹⁰ Levin, R.¹¹ Guleria, A.¹² MacFarlane, M.P.¹³ White, R.L.¹⁴ Einhorn, J.H.¹⁵ Seipp, C.A.¹⁶ Rosenberg, S.A.¹⁷

9
- 0031415591
- An ongoing prospective randomized comparison of interleukin-2 regimens for the treatment of metastatic renal cell cancer
- (1997) Cancer J. Sci. Am. , vol.3 , Issue.SUPPL. 1
- Yang, J.C.¹ Rosenberg, S.A.²

10
- 0023836117
- In vivo antitumor activity of multiple injections of recombinant interleukin-2 alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors
- (1988) Cancer Res. , vol.48 , pp. 260-264
- Iigo, M.¹ Sakurai, M.² Tamura, T.³ Saijo, N.⁴ Hoshi, A.⁵

11
- 0023619262
- In vivo antitumor activity of combinations of interferon-α and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells
- (1987) Int. J. Cancer , vol.40 , pp. 365-371
- Brunda, M.J.¹ Bellantoni, D.² Sulich, V.³

12
- 0024440905
- Indomethacin-enhanced immunotherapy of pulmonary metastases using IL-2 and IFN-α
- (1989) Surgery , vol.106 , pp. 248-256
- Kim, B.¹ Warnaka, P.²

13
- 0023680153
- Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid α-interferon in the treatment of established murine hepatic metastases
- (1988) Cancer Res. , vol.48 , pp. 5810-5817
- Cameron, R.B.¹ McIntosh, J.K.² Rosenberg, S.A.³

14
- 0023806027
- Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro
- (1988) Cancer Res. , vol.48 , pp. 5818-5824
- Weber, J.S.¹ Rosenberg, S.A.²

15
- 0024566466
- Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells
- (1989) J. Natl. Cancer Inst. , vol.81 , pp. 502-511
- Guadagni, F.¹ Schlom, J.² Johnston, W.W.³ Szpak, C.A.⁴ Goldstein, D.⁵ Smalley, R.⁶ Simpson, J.F.⁷ Borden, E.C.⁸ Pestka, S.⁹ Greiner, J.W.¹⁰

16
- 0023224892
- Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models
- (1987) Cancer Res. , vol.47 , pp. 3948-3953
- Winklehake, J.L.¹ Stampfl, S.² Zimmerman, R.J.³

17
- 0024849183
- Combination therapy with interleukin-2 and α-interferon for the treatment of patients with advanced cancer
- (1989) J. Clin. Oncol. , vol.7 , pp. 1863-1874
- Rosenberg, S.A.¹ Lotze, M.T.² Yang, J.C.³ Linehan, W.M.⁴ Seipp, C.⁵ Calabro, S.⁶ Karp, S.E.⁷ Sherry, R.M.⁸ Steinberg, S.⁹ White, D.E.¹⁰

18
- 0024433613
- Concomitant administration of recombinant human interleukin-2 and recombinant interferon α-2A in cancer patients: A Phase I study
- (1989) J. Clin. Oncol. , vol.7 , pp. 1726-1732
- Lee, K.H.¹ Talpaz, M.² Rothberg, J.M.³ Murray, J.L.⁴ Papadopoulos, N.⁵ Plager, C.⁶ Benjamin, R.⁷ Levitt, D.⁸ Gutterman, J.⁹

19
- 0025630051
- A Phase I study of high-dose interleukin-2 in combination with interferon-α2b
- (1990) J. Biol. Response Modif. , vol.9 , pp. 529-537
- Sznol, M.¹ Mier, J.W.² Sparano, J.³ Gaynor, E.R.⁴ Weiss, G.R.⁵ Margolin, K.A.⁶ Bar, M.H.⁷ Hawkins, M.J.⁸ Atkins, M.B.⁹ Dutcher, J.P.¹⁰ Fisher, R.I.¹¹ Boldt, D.H.¹² Doroshow, J.H.¹³ Louie, A.¹⁴ Aronson, F.R.¹⁵

20
- 0025149119
- Phase I study of interleukin-2 and interferon α-2a as outpatient therapy for patients with advanced malignancy
- (1990) J. Clin. Oncol. , vol.8 , pp. 1657-1663
- Hirsh, M.¹ Lipton, A.² Harvey, H.³ Givant, E.⁴ Hopper, K.⁵ Jones, G.⁶ Zeffren, J.⁷ Levitt, D.⁸

21
- 0026719617
- A Phase II trial of interleukin-2 and interferon α-2a in patients with advanced renal cell carcinoma
- (1992) J. Clin. Oncol. , vol.10 , pp. 1124-1130
- Ilson, D.H.¹ Motzer, R.J.² Kradin, R.L.³ Vogelzang, N.J.⁴ Bajorin, D.F.⁵ Scher, H.I.⁶ Nanus, D.⁷ O'Moore, P.⁸ Marathias, K.⁹ Bosl, G.J.¹⁰

22
- 0026322096
- A Phase II trial of interleukin-2 by continuous infusion and interferon by intramuscular injection in patients with renal cell carcinoma
- (1991) Cancer (Phila.) , vol.68 , pp. 1699-1702
- Mittelman, A.¹ Puccio, C.² Ahmed, T.³ Zeffren, J.⁴ Choudhury, A.⁵ Arlin, Z.⁶

23
- 0028809089
- Multi-institutional home-therapy trial of recombinant human IL-2 and IFN-α-2 in progressive metastatic renal cell carcinoma
- (1995) J. Clin. Oncol. , vol.13 , pp. 497-501
- Atzpodien, J.¹ Hanninen, E.L.² Kirchner, H.³ Bodenstein, H.⁴ Pfreundschuh, M.⁵ Rebmann, U.⁶ Metzner, B.⁷ Illiger, H.J.⁸ Jakse, G.⁹ Niesel, T.¹⁰

24
- 0026563367
- Concomitant administration of recombinant human interleukin-2 and recombinant interferon α-2a: An active outpatient regimen in metastatic renal cell carcinoma
- (1992) J. Clin. Oncol. , vol.10 , pp. 414-421
- Figlin, R.A.¹ Belldegrun, A.² Moldawer, N.³ Zeffren, J.⁴ DeKernion, J.⁵

25
- 0007914062
- An outpatient regimen of subcutaneous interleukin-2 plus α-interferon in metastatic renal cell cancer
- (1993) Proc. Am. Soc. Clin. Oncol. , vol.12 , pp. 248
- Dutcher, J.P.¹ Fisher, R.I.² Weiss, G.³ Aronson, F.⁴ Margolin, K.⁵ Louie, A.⁶ Mier, J.⁷

26
- 0007906362
- Outpatient subcutaneous interleukin-2 plus α-interferon in metastatic renal cell cancer: 3 Year follow-up of the Cytokine Working Group study
- (1995) Proc. Am. Soc. Clin. Oncol. , vol.14 , pp. 332
- Dutcher, J.P.¹ Fisher, R.² Weiss, G.³ Aronson, F.⁴ Margolin, K.⁵ Louie, A.⁶ Mier, J.⁷

27
- 17944403024
- Outpatient subcutaneous interleukin-2 and interferon-α for metastatic renal cell cancer: Five year follow-up of the Cytokine Working Group Study
- (1997) Cancer J. Sci. Am. , vol.3 , pp. 157-162
- Dutcher, J.P.¹ Fisher, R.I.² Weiss, G.³ Aronson, F.⁴ Margolin, K.⁵ Louie, A.⁶ Mier, J.⁷ Caliendo, G.⁸ Sosman, J.A.⁹ Eckardt, J.R.¹⁰ Ernest, M.L.¹¹ Doroshow, J.¹² Atkins, M.¹³

28
- 7144227930
- Recombinant human interleukin-2, recombinant human interferon α-2a, or both in metastatic renal cell carcinoma
- (1998) N. Engl. J. Med. , vol.338 , pp. 1272-1278
- Negrier, S.¹ Escudier, B.² Lasset, C.³ Douillard, J.-Y.⁴ Savary, J.⁵ Chevreau, C.⁶ Ravaud, A.⁷ Mercatello, A.⁸ Peny, J.⁹ Mousseau, M.¹⁰ Philip, T.¹¹ Tursz, T.¹²

29
- 0026600296
- Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cells
- (1991) Biochem. Biophys. Res. Commun. , vol.182 , pp. 1232-1239
- Schwartz, E.L.¹ Hoffman, M.² O'Connor, C.³ Wadler, S.⁴

30
- 0030965515
- Biochemical modulation of 5-fluorouracil with murine interferon-α/β against murine renal cell carcinoma
- (1997) Int. J. Urol. , vol.4 , pp. 163-168
- Marumo, K.¹ Oya, M.² Murai, M.³

31
- 0025360346
- Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump
- (1990) Cancer (Phila.) , vol.66 , pp. 237-241
- Damascelli, B.¹ Marchiano, A.² Spreafico, C.³ Lutman, R.⁴ Salvetti, M.⁵ Bonalumi, M.G.⁶ Mauri, M.⁷ Garbagnati, F.⁸ DelNero, A.⁹ Comeri, G.¹⁰ Conti, G.¹¹ Coppoli, S.¹² Benetti, G.¹³ Tralongo, P.¹⁴ Belussi, D.¹⁵

32
- 0028947958
- Interferon-α/5-fluorouracil: A novel outpatient chemo/Immunotherapy for progressive metastatic renal cell carcinoma
- (1995) Cancer Biother. , vol.10 , pp. 21-24
- Hanninen, E.L.¹ Poliwoda, H.² Atzpodien, J.³

33
- 0007913906
- A Phase II trial of low-dose continuous infusion 5-fluorouracil plus interferon-α in patients with advanced renal cell carcinoma
- (1993) Proc. Soc. Biol. Ther.
- Sparano, J.A.¹ Dutcher, J.P.² Wiernik, P.H.³ Wadler, S.⁴ Caliendo, G.⁵ Nobile, L.⁶

34
- 0031450065
- Treatment of renal cell carcinoma with 5-fluorouracil and α-interferon
- (1997) Urology , vol.50 , pp. 863-868
- Gebrosky, N.P.¹ Koukol, S.² Nseyo, U.O.³ Carpenter, C.⁴ Lamm, D.L.⁵

35
- 0029834011
- A Phase II trial of interferon-α and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
- (1996) Cancer (Phila.) , vol.78 , pp. 1085-1088
- Elias, L.¹ Blumenstein, B.A.² Kish, J.³ Flanigan, R.C.⁴ Wade, J.L.⁵ Lowe, B.A.⁶ Goodwin, J.W.⁷ Crawford, E.D.⁸

36
- 0029993158
- Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-α and 5-fluorouracil
- (1996) J. Urol. , vol.156 , pp. 18-21
- Hofmockel, G.¹ Langer, W.² Theiss, M.³ Gruss, A.⁴ Frohmuller, H.G.W.⁵

37
- 0030712258
- Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma
- (1997) Cancer (Phila.) , vol.80 , pp. 2128-2132
- Ellerhorst, J.A.¹ Sella, A.² Amato, R.J.³ Tu, S.-M.⁴ Millikan, R.E.⁵ Finn, L.D.⁶ Banks, M.⁷ Logothetis, C.J.⁸

38
- 0031833035
- Outpatient treatment with subcutaneous interleukin-2 and interferon α administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: Results of a sequential nonrandomized Phase II study
- (1998) J. Clin. Oncol. , vol.16 , pp. 2505-2513
- Tourani, J.-M.¹ Pfister, C.² Berdah, J.-F.³ Benhammouda, A.⁴ Salze, P.⁵ Monnier, A.⁶ Paule, B.⁷ Guillet, P.⁸ Chretien, Y.⁹ Brewer, Y.¹⁰ DiPalma, M.¹¹ Untereiner¹² Malaurie, E.¹³ Tadrist, Z.¹⁴ Pavlovitch, J.-M.¹⁵ Hauteville, D.¹⁶ Mejean, A.¹⁷ Azagury, M.¹⁸ Mayeur, D.¹⁹ Lucas, V.²⁰ more..

39
- 0031904556
- Subcutaneous interleukin-2, interferon α-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: A multicenter Phase II trial
- (1998) J. Clin. Oncol. , vol.16 , pp. 2728-2732
- Ravaud, A.¹ Audhuy, B.² Gomez, F.³ Escudier, B.⁴ Lesimple, T.⁵ Chevreau, C.⁶ Douillard, J.-Y.⁷ Caty, A.⁸ Geoffrois, L.⁹ Ferrero, J.-M.¹⁰ Linassier, C.¹¹ Drevon, M.¹² Negrier, S.¹³

40
- 0030859233
- A Phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cell cancer
- (1996) Eur J. Cancer , vol.33 , pp. 1149-1151
- Savage, P.¹ Costelna, D.² Moore, J.³ Gore, M.E.⁴

41
- 0030420513
- A Phase II study of interferon-α, interleukin-2 and 5-fluorouracii in advanced renal carcinoma: Clinical data and laboratory evidence of protease activation
- (1996) Br. J. Urol. , vol.77 , pp. 638-649
- Joffe, J.K.¹ Banks, R.E.² Forbes, M.A.³ Hallam, S.⁴ Jenkins, A.⁵ Patel, P.M.⁶ Hall, G.D.⁷ Velikova, G.⁸ Adams, J.⁹ Crossley, A.¹⁰ Johnson, P.W.¹¹ Whicher, J.T.¹² Selby, P.J.¹³

42
- 0001080031
- Randomized study of interleukin-2 and interferon with or without 5-FU (FUCY study) in metastatic renal cell carcinoma
- (1997) Proc. Am. Soc. Clin. Oncol. , vol.16 , pp. 326
- Negrier, S.¹ Escudier, B.² Douillard, J.Y.³ Lesimple, T.⁴ Rossi, J.F.⁵ Viens, P.⁶ DiStefano-Louineau, D.⁷ Drevon, M.⁸ Gomez, F.⁹ Caty, A.¹⁰

43
- 0027488554
- Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell carcinoma
- (1993) Eur J. Cancer , vol.29 A , pp. 56-58
- Atzpodien, J.¹ Kirchner, H.² Hanninen, E.³ Deckert, M.⁴ Fenner, M.⁵ Poliwoda, H.⁶

44
- 0029655348
- Interleukin-2 based home therapy of metastatic renal cell carcinoma: Risks and benefits in 215 consecutive single institution patients
- (1996) J. Urol. , vol.155 , pp. 19-25
- Hanninen, E.L.¹ Kirchner, H.² Atzpodien, J.³

45
- 0001360165
- Risk and longer-term outcome in metastatic renal cell carcinoma patients receiving SC interleukin-2, SC interferon-α 2A, and IV 5-fluorouracil
- (1998) Proc. Am. Soc. Clin. Oncol. , vol.17 , pp. 310
- Kirchner, H.¹ Buer, J.² Probst-Kepper, M.³ Franzke, A.⁴ Hoffmann, R.⁵ Wittke, F.⁶ Ganser, A.⁷ Atzpodien, J.⁸

46
- 0029186885
- Biochemotherapy of advanced metastatic renal-cell carcinoma: Results of the combination of interleukin-2, α-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid
- (1995) World J. Urol. , vol.13 , pp. 174-177
- Atzpodien, J.¹ Kirchner, H.² Duensing, S.³ Hanninen, E.L.⁴ Franzke, A.⁵ Buer, J.⁶ Probst, M.⁷ Anton, P.⁸ Poliwoda, H.⁹

47
- 0031424976
- Interleukin-2-based therapy for metastatic renal cell cancer: The Cytokine Working Group Experience, 1989-1997
- (1997) Cancer J. Sci. Am. , vol.3 , Issue.SUPPL. 1
- Dutcher, J.P.¹ Atkins, M.² Fisher, R.³ Weiss, G.⁴ Margolin, K.⁵ Aronson, F.⁶ Sosman, J.⁷ Lotze, M.⁸ Gordon, M.⁹ Logan, T.¹⁰ Mier, J.¹¹

48
- 0001538448
- Low dose interleukin-2: Single agent and combination regimens
- N. J. Vogelzang, P. T. Scardino, W. U. Shipley, and D. S. Coffey (eds.), Comprehensive Textbook of Genitourinary Oncology, Ed 2. Philadelphia: Williams and Wilkins
- (2000) , pp. 218-234
- Bukowski, R.M.¹ Dutcher, J.P.²

49
- 0027417437
- The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology
- (1993) J. Natl. Cancer Inst. , vol.85 , pp. 365-376
- Aaronson, N.K.¹ Ahmedzai, S.² Bergman, B.³ Bullinger, M.⁴ Cull, A.⁵ Duez, N.J.⁶ Filiberti, A.⁷ Flechtner, H.⁸ Fleishman, S.B.⁹ DeHaes, J.C.¹⁰

50
- 0023444264
- The measure of symptom distress
- (1987) Sem. Oncol. Nursing , vol.3 , pp. 248-256
- McCorkle, R.¹

51
- 0038133532
- Quality of life (QOL) assessment of renal cancer patients treated with interleukin-2, interferon-α and 5-fluorouracil
- (1998) Proc. Am. Soc. Clin. Oncol. , vol.17 , pp. 67
- Plasse, T.¹ Goss, T.² Dutcher, J.³ Logan, T.⁴ Gordon, M.⁵ Clark, J.⁶ Weiss, G.⁷ Margolin, K.⁸ Atkins, M.⁹

52
- 15844402081
- European studies of interleukin-2 in metastatic renal cell cancer
- (1994) Proc. Am. Soc. Clin. Oncol. , vol.13 , pp. 247
- Atzpodien, J.¹ Kirchner, H.² Hanninen, E.L.³ Deckert, M.⁴ Franzke, A.⁵ Poliwoda, H.⁶

53
- 0033848237
- Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe
- (2000) Cancer J. Sci. Am. , vol.6 , Issue.SUPPL. 1
- Negrier, S.¹ Maral, J.² Drevon, M.³ Vinke, J.⁴ Escudier, B.⁵ Philip, T.⁶

54
- 0002258098
- Cytoreduction nephrectomy in metastatic renal cancer: The results of Southwest Oncology Group Trial 8949
- (2000) Proc. Am. Soc. Clin. Oncol. , vol.19 , pp. 2
- Flanigan, R.C.¹ Blumenstein, B.A.² Salmon, S.³ Crawford, E.⁴

55
- 0026587391
- Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy
- (1992) Cancer (Phila.) , vol.69 , pp. 1850-1855
- Sherry, R.M.¹ Pass, H.I.² Rosenberg, S.A.³ Yang, J.C.⁴

56
- 0031800250
- Resection of metastatic renal cell carcinoma
- (1998) J. Clin. Oncol. , vol.16 , pp. 2261-2266
- Kavolius, J.P.¹ Mastorakos, D.P.² Pavlovich, C.³ Russo, P.⁴ Burt, M.E.⁵ Brady, M.S.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.